Dear Doctor - Participate in the Survey on breast cancer " The American Cancer Society’s most recent estimates for breast cancer in the United States are for 2018. In 2018, an estimated 266,120 new cases of invasive breast cancer will be diagnosed in women in the U.S. This includes 88060 cases of ductal carcinoma in situ (DCIS), which is a non-invasive form of breast cancer. Additionally, it is estimated that 63,960 women will die from breast cancer this year. However, death rates have been decreasing since 1989 due largely to improvements in screening and treatment advances. It is estimated that there are 3,410,000 women alive today who have been diagnosed with breast cancer at some point during their lives. Risk factors for developing breast cancer include: • being female and getting older – about two out of three invasive breast cancers are found in women who are 65 or older; • personal history of certain types of cancer – including ovarian cancer, ductal carcinoma in situ (DCIS), and lobular carcinoma in situ (LCIS); • family history of breast cancer – about 5 to 10% of invasive breast cancers are thought to be hereditary; • having dense breasts – denser breasts have more connective and glandular tissue than fatty tissue and can be more difficult to evaluate on a mammogram; • previous abnormal breast biopsy – an abnormal biopsy is one where atypical cells are found; Participate in Surveys "
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Review looks at potential treatment targets in the tumor microenvironment.
3.
Even when they are not paying attention, children are still learning.
4.
The Benefits of Exercise for Substance Use Disorders.
5.
The top three drugs for multiple myeloma treatment upfront are four.
1.
The New Era of Oncology: Key Updates and Clinical Insights
2.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
3.
Decoding Granular Cell Tumor: What You Need to Know
4.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
5.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Navigating the Complexities of Ph Negative ALL - Part XI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation